Table 2.
Method | Target | Detection range | Ref. |
Architect | HBsAg | 0.05-250.0 IU/mL | [12] |
Elecsys | HBsAg | NA | [15] |
UV spectrophotometry | HBV DNA | 0.4-15000 ng/µL | [23] |
In-house assays based on real-time PCR | HBV DNA | 101-108 copies/reaction | [27] |
HBV DNA | 50-108 IU/mL | [19] | |
Digital PCR | HBV DNA | Single copy | [39] |
IAM | |||
LAMP | HBV DNA | 48-108 IU/mL | [43] |
TMA | HBV DNA | 5 × 103-5 × 108 GE/mL | [47] |
NASBA | HBV DNA | 103-109 copies/mL | [52] |
HBV DNA | 102-109 IU/mL | [53] | |
RCA | HBV DNA | 103-108 IU/mL | [57] |
Biosensors | |||
Electrochemical biosensors | HBV DNA | 3.96 × 10-7-1.32 × 10-6 mol/L | [65] |
HBV DNA | 1.01 × 10-8-1.62 × 10-6 mol/L | [66] | |
QCM biosensors | HBV DNA | 0.02-0.14 mg/mL | [67] |
HBV DNA | 8.6 pg/L1 | [68] | |
Microcantilever biosensors | HBV DNA | 23.1 fmol/L-2.31 nmol/L | [69] |
SPR biosensors | HBV DNA | 2 fg/mL1 | [45] |
Only the limits of detection were given in these two papers. HBsAg: Hepatitis B surface antigen; HBV: Hepatitis B virus; NA: Not available; LAMP: Loop-mediated isothermal amplification; TMA: Transcription-mediated amplification; NASBA: Nucleic acid sequence-based amplification; RCA: Rolling circle amplification; QCM: Quartz crystal microbalance; SPR: Surface plasmon resonance; IAM: Isothermal amplification methods.